Login / Signup

Treatments for alopecia areata: a network meta-analysis.

Miriam Mateos-HaroMonica Novoa-CandiaGuillermo Sánchez VanegasAndrea Correa-PérezAndrea Gaetano GilSilvia Fernández-GarcíaDaniel Ortega-QuijanoMayra Gizeth Urueña RodriguezDavid Saceda-CorraloTayeb Bennouna-DaleroLucia GiraldoJaqueline TomlinsonSergio Vaño-GalvánJavier Zamora
Published in: The Cochrane database of systematic reviews (2023)
We found that treatment with baricitinib results in an increase in short- and long-term hair regrowth compared to placebo. Although we found inconclusive results for the risk of serious adverse effects with baricitinib, the reported small incidence of serious adverse events in the baricitinib arm should be balanced with the expected benefits. We also found that the impact of other treatments on hair regrowth is very uncertain. Evidence for health-related quality of life is still scant.
Keyphrases
  • risk factors
  • clinical trial
  • combination therapy
  • phase iii
  • smoking cessation